Parlevliet ET, Wang Y, Geerling JJ, Schroder-Van der Elst JP, Picha K, ONeil K, et al
In other medications, this is a desirable effect to assist in disease management such as sodiumglucose transport protein 2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor (GLP-1) agonists when used to treat type 2 diabetes mellitus and topiramate when used for migraine prophylaxis and for patients with binge-eating disorder
M., Jedry- chowski, M
The peptide itself is typically administered subcutaneously, where it is absorbed into the bloodstream, distributed through the body, and then cleared by enzymatic degradation and renal excretion
Right medication, right pricing , right quality & right care choice is the new normal To view or add a comment, sign in Indias GLP-1 market is entering a turning pointand its being shaped by evolving patent landscapes and rising demand